As of 2024-12-15, the Intrinsic Value of Haemonetics Corp (HAE) is
71.57 USD. This HAE valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 81.19 USD, the upside of Haemonetics Corp is
-11.80%.
The range of the Intrinsic Value is 45.95 - 136.38 USD
71.57 USD
Intrinsic Value
HAE Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
45.95 - 136.38 |
71.57 |
-11.8% |
| DCF (Growth 10y) |
72.60 - 194.38 |
107.33 |
32.2% |
| DCF (EBITDA 5y) |
66.44 - 120.99 |
88.40 |
8.9% |
| DCF (EBITDA 10y) |
90.14 - 165.49 |
120.03 |
47.8% |
| Fair Value |
61.63 - 61.63 |
61.63 |
-24.09% |
| P/E |
75.28 - 101.08 |
86.06 |
6.0% |
| EV/EBITDA |
49.18 - 107.27 |
79.27 |
-2.4% |
| EPV |
16.72 - 28.02 |
22.37 |
-72.4% |
| DDM - Stable |
19.40 - 57.15 |
38.28 |
-52.9% |
| DDM - Multi |
46.53 - 108.51 |
65.36 |
-19.5% |
HAE Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
4,077.36 |
| Beta |
1.47 |
| Outstanding shares (mil) |
50.22 |
| Enterprise Value (mil) |
5,003.04 |
| Market risk premium |
4.60% |
| Cost of Equity |
10.39% |
| Cost of Debt |
4.28% |
| WACC |
9.25% |